SCHEMBL19255997

SCHEMBL19255997

CC(C)CC(=O)O[C@H]1C(OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C(CO)O[C@@H]1O[C@@H]1CC(C(=O)O)[C@H]2CCC34CC(CC[C@H]3[C@]2(C)C1)C(=O)C4O

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.78
HPSE Q9Y251 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765566 0.93 MAPT (0.89) MAPTHPSE
SCHEMBL20456989 0.93 MAPT (0.89) MAPTHPSE
SCHEMBL15634985 0.92 MAPT (0.88) MAPTHPSE
Potassium Ion SCHEMBL30190052 0.87 MAPT (1.00) MAPTHPSE
Potassium Ion SCHEMBL380009 0.87 MAPT (1.00) MAPTHPSE
Potassium Ion SCHEMBL28493998 0.87 MAPT (1.00) MAPTHPSE
Potassium Ion SCHEMBL29767873 0.87 MAPT (1.00) MAPTHPSE
Water SCHEMBL6357796 0.87 MAPT (0.99) MAPTHPSE
SCHEMBL19248228 0.83 MAPT (0.71) MAPTHPSE
SCHEMBL25014383 0.81 MAPT (0.78) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170232007-A1 METHODS AND COMPOSITIONS FOR TREATING ALCOHOL USE DISORDERS SANNA PIETRO PAOLO (US) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170232007-A1 METHODS AND COMPOSITIONS FOR TREATING ALCOHOL USE DISORDERS HSD3B1, HSD11B1, HSD3B2 MAPT 4186/4885HPSE 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.